Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201205149 Principal Investigator: Ademuyiwa, Foluso
Title: The BEACON Study (BrEAst Cancer Outcomes with NKTR-102): A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 versus Treatment of Physician’s Choice (TPC) in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with an Anthracycline, a Taxane, and Capecitabine
Phase: III Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to test whether NKTR-102 compared with standard treatment for breast cancer is safe and effective in treating patients with advanced breast cancer. This study will look at how cancer responds to the study treatment. It will also look at the side effects of NKTR-102 and (in some patients) it will examine how long NKTR-102 stays in their blood.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)